KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Oct 30, 2018 $112.43 $114.38 $109.97 $114.19 1 530 799
Oct 29, 2018 $117.67 $118.09 $109.74 $112.26 2 021 959
Oct 26, 2018 $114.06 $118.77 $113.01 $116.27 2 204 083
Oct 25, 2018 $114.05 $119.39 $111.81 $117.16 3 576 441
Oct 24, 2018 $125.76 $126.50 $110.59 $110.99 7 219 790
Oct 23, 2018 $121.96 $124.26 $119.33 $123.00 1 227 086
Oct 22, 2018 $126.79 $127.07 $122.95 $123.92 1 086 140
Oct 19, 2018 $126.74 $128.99 $125.40 $125.89 1 166 926
Oct 18, 2018 $129.09 $129.26 $124.96 $126.56 891 174
Oct 17, 2018 $127.32 $129.57 $125.83 $128.94 934 223
Oct 16, 2018 $122.63 $128.13 $122.35 $127.70 1 379 552
Oct 15, 2018 $121.02 $123.52 $120.00 $121.49 1 059 970
Oct 12, 2018 $122.57 $122.96 $118.16 $121.94 1 841 535
Oct 11, 2018 $124.01 $124.50 $118.25 $119.31 1 991 085
Oct 10, 2018 $129.56 $130.12 $123.76 $123.99 1 615 906
Oct 09, 2018 $129.66 $132.27 $128.54 $130.58 1 384 546
Oct 08, 2018 $131.03 $132.20 $127.28 $129.46 1 356 425
Oct 05, 2018 $133.61 $136.07 $130.02 $130.82 1 727 097
Oct 04, 2018 $136.56 $136.71 $132.59 $133.61 1 160 822
Oct 03, 2018 $136.17 $138.11 $135.13 $136.71 2 111 747
Oct 02, 2018 $137.00 $137.87 $134.08 $135.88 2 386 882
Oct 01, 2018 $139.14 $140.00 $136.90 $137.12 1 911 042
Sep 28, 2018 $138.16 $140.77 $137.92 $139.01 2 943 123
Sep 27, 2018 $135.30 $138.87 $135.10 $138.27 1 757 302
Sep 26, 2018 $132.47 $137.48 $131.27 $135.61 3 878 620
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT